相关实验视频

Updated: Sep 11, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.9K

随机第一阶段试验结果显示,empasiprubart可安全和可持续地抑制古典和乳素补充通路

Inge Van de Walle1, Laura Bracke2, Heidi Gytz Olesen3

  • 1argenx, Ghent, Belgium. IVandeWalle@argenx.com.

Nature communications
|August 16, 2025
PubMed
概括

恩帕西普鲁巴特是一种新型抗体,向补充因子2 (C2),以抑制参与疾病的补充通路. 临床试验表明它是安全的,耐受性很好,并有效地降低长期的C2水平.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

539
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

相关概念视频

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.5K